The Aporia
How a first-of-its-kind nasal spray is designed to treat a common heart condition. (2026, October 30). CBS News. https://www.cbsnews.com/video/how-a-first-of-its-kind-nasal-spray-is-designed-to-treat-a-common-heart-condition/
“How a first-of-its-kind nasal spray is designed to treat a common heart condition.” CBS News, 30 Oct. 2026, https://www.cbsnews.com/video/how-a-first-of-its-kind-nasal-spray-is-designed-to-treat-a-common-heart-condition/.
“How a first-of-its-kind nasal spray is designed to treat a common heart condition.” CBS News, October 30, 2026. https://www.cbsnews.com/video/how-a-first-of-its-kind-nasal-spray-is-designed-to-treat-a-common-heart-condition/.
Dated from the outlet's own feed. Check the original for its byline.
CBS News reported on October 30, 2026, the approval by the FDA of a first-of-its-kind nasal spray to treat PSVT, a heart condition that affects up to 2 million Americans. PSVT causes sudden episodes of rapid heartbeat, which can be unpredictable and disruptive for those affected. The new prescription nasal spray is designed as a self-administered treatment specifically for this condition.